Concentrix (CNXC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
13 Feb, 2026Executive summary
Annual meeting scheduled for March 25, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by March 24, 2026, or March 20, 2026, for 401(k) plan shares.
Voting matters and shareholder proposals
Election of nine directors for one-year terms expiring at the 2027 annual meeting.
Ratification of Ernst & Young LLP as independent public accounting firm for fiscal year 2026.
Advisory approval of executive compensation (say-on-pay) for named executive officers.
Approval of an amendment to the 2020 Stock Incentive Plan to increase shares available for issuance.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Nine director nominees are presented for election, each for a one-year term.
Nominees include Chris Caldwell, Chih-Kai Cheng, LaVerne H. Council, Jennifer Deason, Kathryn Hayley, Kathryn Marinello, Bilge Ogut, Dennis Polk, and Ann Vezina.
Latest events from Concentrix
- AI-driven IX suite accelerates margin growth and cash flow, supporting debt reduction and future value.CNXC
Canaccord Genuity's 46th Annual Growth Conference - Q2 revenue up 1.9% with record cash flow, but margins fell amid restructuring costs.CNXC
Q2 2026 - All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 2026 - Revenue up 5.4% to $2.5B, but margins and net income declined despite strong AI-driven growth.CNXC
Q1 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing - Record revenue and cash flow in 2025, with 2026 growth expected despite a goodwill impairment.CNXC
Q4 2025 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 2024 - FY25 guidance projects modest revenue growth, margin expansion, and higher free cash flow.CNXC
Q4 2024